Safety study of FHND1002 granules in healthy adults
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests a new medication called FHND1002 in healthy adults aged 18 to 45. The goal is to check its safety, how well the body tolerates it, and how it is processed. It is one of the first tests in humans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- You are in good general health with no major medical conditions.
- Your body mass index (BMI) is between 19 and 26.
- If you are male, you weigh at least 50 kg (110 lbs); if female, at least 45 kg (99 lbs).
- You agree not to plan a pregnancy and to use effective birth control during the study and for 3 months after.
- You have not taken any prescription or over-the-counter drugs, herbal supplements, or vitamins in the past 14 days (with some exceptions discussed by the study doctor).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational oral medication, FHND1002, for people with ALS whose disease has been progressing for less than 2 years. It aims to slow further decline in muscle function and breathing ability.
This trial studies a new drug called FB418 to see if it's safe and how the body handles it. It first tests single doses in younger healthy men, then multiple doses, and also includes an optional group for healthy older adults.
This study tests an investigational drug called NB-4746 for people with ALS. The goal is to see if it can slow the progression of the disease. It is for people diagnosed within the last couple of years who are still able to eat and breathe on their own.
This trial tests a new drug called XT-150 for ALS. The goal is to see if it is safe and how the body handles it. It may be an option if you have had ALS symptoms for up to 3 years and have good enough lung function.
This trial tests a single injection of SNUG01 into the spinal fluid to see if it is safe and could help people with ALS. It is an early study to check for side effects and how well the treatment works.
This trial tests an experimental oral medication called usnoflast for people with ALS. It aims to see if the drug can slow the disease's progression.
Hear when a new Amyotrophic Lateral Sclerosis (ALS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.